- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05597293
FreeStyle Libre Monitoring in T2DM
Effect of Introduction of FreeStyle Libre Monitoring on Glycaemic Control in People With Type 2 Diabetes Mellitus (T2DM)
The goal of this clinical trial is to learn if blood sugar monitoring using a FreeStyle Libre device can improve overall Diabetes control in people with Type 2 Diabetes.
The main questions it aims to answer are:
- What is the effect of monitoring using the FreeStyle Libre device for a period of 12 weeks on the blood sugar control of people with Type 2 Diabetes?
- Can monitoring using the FreeStyle Libre device improve the quality of life of people with Type 2 diabetes?
Participants will be asked to wear one of two brands of FreeStyle Libre devices. In one group, participants will have 3 visits, while those in the second group, they will have 4 visits.
Researchers will compare the improvement in the sugar control for the individuals but also compare between the 2 groups.
Study Overview
Status
Conditions
Detailed Description
This is a prospective, randomised, open-labelled, non-CTIMP, pilot study. Participants meeting the inclusion criteria and who have consented to participate in the study will be randomised on a 1:1 ratio to receive either Libre 2 or Libre pro iQ. Randomisation will be carried out using an online randomisation tool to allocate a participant to a treatment group.
The study will consist of three visits (Libre 2 arm) and four visits (Libre pro iQ arm). The study will be completed over 12 weeks.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Chair in Academic Diabetes, Endocrinology and Metabolism
- Phone Number: +441482675387
- Email: thozhukat.sathyapalan@hyms.ac.uk
Study Locations
-
-
-
Hull, United Kingdom, HU32RW
- Recruiting
- Hull University Teaching Hospitals NHS Trust, Academic diabetes, Endocrinology and metabolism
-
Contact:
- Thozhukat Sathyapalan, MD FRCP
- Phone Number: +441482675312
- Email: thozhukat.sathyaplan@hyms.ac.uk
-
Contact:
- Najeeb Shah, MBBS, MRCP
- Phone Number: +441482675387
- Email: hyns17@hyms.ac.uk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Males and females living with type 2 diabetes mellitus (T2DM) who are aged ≥ 18 and ≤ 75 years
- On one or more non-insulin glucose lowering agent(s)
- HbA1c ≥ 69 mmol/mol
- Able to provide written informed consent
Exclusion Criteria:
- Participants with a life expectancy of less than 1 year
- Participants with cognitive dysfunction or neurological disorder, which will interfere with regular, flash glucose monitoring
- Participants with chronic kidney disease (CKD) with eGFR < 45ml/min/1.73m2 or decompensated liver disease or decompensated congestive cardiac failure
- Myocardial infarction in the preceding 3 months or if percutaneous coronary intervention planned in the next 6 months
- Participants on supra-physiological doses of steroids, for example, Prednisolone for the treatment of Rheumatoid arthritis
- Participants on active dialysis or planned for dialysis treatment during the study
- Currently participating in another device or drug study that could affect glucose measurements or management
- Women who are pregnant, breastfeeding or planning to become pregnant. Women should use a reliable form of contraception throughout the study
- Participants who are already using continuous glucose monitoring (CGM)
- Participants who have pacemakers, implanted cardioverter defibrillator devices or neurostimulators
- Participants with an allergy to medical grade adhesive
- A blood transfusion in the preceding 3 months or a planned blood transfusion during the course of the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: FreeStyle Libe 2
Participants in this group will wear the FreeStyle Libre 2 device
|
Glucose monitoring in patients with type 2 diabetes using FreeStyle Libre 2
|
Active Comparator: FreeStyle Libre pro iQ
Participants in this arm will wear the FreeStyle Libre pro iQ device
|
Glucose monitoring in patients with type 2 diabetes using FreeStyle Libre pro iQ
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of participants with a change in HbA1c of 5.5 mmol/mol or more
Time Frame: 12 weeks
|
The number of participants with a change in HbA1c of 5.5 mmol/mol or more at the end of the study compared to baseline HbA1c
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in the Diabetes Quality of Life (DQOL) score
Time Frame: 12 weeks
|
Change in Diabetes Quality of Life (DQOL) score from baseline to end of the study.
The total scores range from 0 (lowest possible quality of life) to 100 (highest possible quality of life).
Higher scores mean a better outcome
|
12 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Thozhukat Sathyapalan, FRCP,FACP, University of Hull
Publications and helpful links
General Publications
- Edge J, Acerini C, Campbell F, Hamilton-Shield J, Moudiotis C, Rahman S, Randell T, Smith A, Trevelyan N. An alternative sensor-based method for glucose monitoring in children and young people with diabetes. Arch Dis Child. 2017 Jun;102(6):543-549. doi: 10.1136/archdischild-2016-311530. Epub 2017 Jan 30.
- Davies MJ, D'Alessio DA, Fradkin J, Kernan WN, Mathieu C, Mingrone G, Rossing P, Tsapas A, Wexler DJ, Buse JB. Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2018 Dec;41(12):2669-2701. doi: 10.2337/dci18-0033. Epub 2018 Oct 4.
- Deshmukh H, Wilmot EG, Gregory R, Barnes D, Narendran P, Saunders S, Furlong N, Kamaruddin S, Banatwalla R, Herring R, Kilvert A, Patmore J, Walton C, Ryder REJ, Sathyapalan T. Effect of Flash Glucose Monitoring on Glycemic Control, Hypoglycemia, Diabetes-Related Distress, and Resource Utilization in the Association of British Clinical Diabetologists (ABCD) Nationwide Audit. Diabetes Care. 2020 Sep;43(9):2153-2160. doi: 10.2337/dc20-0738. Epub 2020 Jul 15.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 301630
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type2diabetes
-
University of Erlangen-Nürnberg Medical SchoolBayerRecruiting
-
Chong Kun Dang PharmaceuticalCompletedType2DiabetesKorea, Republic of
-
University of ManitobaDiabetes Canada; Children's Hospital Research Institute of Manitoba (CHRIM)Active, not recruitingPrevention | Type2DiabetesCanada
-
Methodist Health SystemActive, not recruitingDiabetes | Type2diabetesUnited States
-
Universidade Nova de Lisboacruz vermelha hospitalRecruitingObesity | Bariatric Surgery Candidate | Metabolic Disease | Type2diabetesPortugal
-
Diabetes Foundation, IndiaNational Diabetes Obesity and Cholesterol FoundationRecruiting
-
Adrian VellaRecruiting
-
Bozok UniversityRecruitingDiabetes Mellitus | Stress | Motivational Interviewing | Type2diabetes | Well-Being, PsychologicalTurkey
-
Tel Aviv UniversityNot yet recruiting
-
Wake Forest University Health SciencesAmerican Diabetes AssociationRecruiting
Clinical Trials on Glucose monitoring using FreeStyle Libre 2
-
Region SkaneRecruitingDiabetes, Gestational | Pregnancy in Diabetic | Gastric Bypass Status for Obesity Complicating Pregnancy, Childbirth, or the Puerperium | Blood Glucose Self MonitoringSweden
-
Nanjing First Hospital, Nanjing Medical UniversityUnknown
-
Jessa HospitalUnknownFlash Glucose Monitoring | Skin ReactionsBelgium
-
Abbott Diabetes CareCompleted
-
Shanghai General Hospital, Shanghai Jiao Tong University...UnknownDiabetes Mellitus, Type 2 | Flash Glucose MonitoringChina
-
Abbott Diabetes CareCompleted
-
Jessa HospitalUnknownMetabolic Control | Flash Glucose MonitoringBelgium
-
Abbott Diabetes CareCompleted
-
Abbott Diabetes CareCompleted